PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Drug Development, MirZyme Therapeutics, Birmingham, UK.\', \'Department of Cardiology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.\', \'School of Health Sciences, University of Southampton, Southampton, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/bph.15582
?:hasPublicationType
?:journal
  • British journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34085281
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.603
?:rankingScore_hIndex
  • 186
is ?:relation_isRelatedTo_publication of
?:title
  • The impact of COVID-19 on pregnancy and therapeutic drug development.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34085281>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34085281>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all